Endpoint definition
↥321302 individuals
Apply sex-specific rule None
321302
Check conditions None
321302
Check pre-conditions, main-only, mode, ICD version
6015
Check minimum number of events None
6015
Extra metadata
321302 individuals
Apply sex-specific rule None
321302
Check conditions None
321302
Check pre-conditions, main-only, mode, ICD version
6015
Check minimum number of events None
6015
Extra metadata
List of similar endpoints to Melanocytic naevi based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
All | Female | Male | |
---|---|---|---|
Number of individuals | 6131 | 3957 | 2174 |
Unadjusted prevalence (%) | 1.99 | 2.28 | 1.61 |
Mean age at first event (years) | 48.77 | 45.62 | 54.51 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | 0.01 | 0.92 [0.59, 1.43] | 7.1e-1 | 279 |
15 years | 0.00 | 0.71 [0.48, 1.04] | 7.8e-2 | 136 |
5 years | 0.00 | 1.61 [1.14, 2.26] | 6.6e-3 | 82 |
1 year | 0.00 | 1.39 [0.76, 2.54] | 2.8e-1 | 13 |
Index endpoint: CD2_BENIGN_MELANOCYTIC – Melanocytic naevi
GWS hits: 0
before Melanocytic naevi
after Melanocytic naevi
Loading survival analyses plot
Loading survival analyses table